This compound is a prodrug of adefovir, designed to improve oral bioavailability of the parent antiviral agent. It is utilized as a pharmaceutical raw material in the manufacturing of antiviral research compounds.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing N6-Hydroxymethyl Adefovir Dipivoxil?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Adefovir Dipivoxil Dimer
pharmaceutical intermediate
Adefovir dipivoxil
pharmaceutical raw material
Sisomicin
pharmaceutical raw material
2-methyl-ethinylestradiol
pharmaceutical raw material
Paroxetine EP Impurity A HCl
pharmaceutical raw material
3,4,5-trihydroxy-6-oxooxane-2-carbaldehyde
pharmaceutical raw material
[2,2-dimethylpropanoyloxymethoxy-[2-[6-(hydroxymethylamino)purin-9-yl]ethoxymethyl]phosphoryl]oxymethyl 2,2-dimethylpropanoate
YJHTYKJKQVFIIC-UHFFFAOYSA-N
CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)NCO)OCOC(=O)C(C)(C)C
Sourcing N6-Hydroxymethyl Adefovir Dipivoxil?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.